Afghanistan’s crystal meth boom is rooted in this plant

2021 ◽  
pp. 18-19
Author(s):  
Lynzy Billing, special to C&EN
Keyword(s):  
Author(s):  
Xavier Heckert

Pervitin is a drug developed in Nazi Germany by the pharmaceutical company Temmler, before the start of World War II. Originally sold without prescription to the population, it was claimed to suppress fatigue, make one more alert, reduce hunger, and help fight depression. The main ingredient of this wonder drug was methamphetamine, the primary component of what we now call crystal meth. This miracle drug’s effectiveness against fatigue caught the attention of the director of the Research Institute of Defense Physiology of the German forces, Dr. Otto Ranke, who considered that fatigue was enemy number one of a soldier during battle. An order of thirty five million Pervitin tablets were purchased for the Wehrmacht’s invasion of France in May 1940 to increase effectivity of the campaign that relied especially on speed for success. History will claim that the use of mobile warfare over positional warfare with Germany’s motorized army, French high command mistakes, and an equipment disadvantage led to the ultimate defeat. My research aims to show that Pervitin was a crucial factor in the iron force of the blitzkrieg by the Wehrmacht and Luftwaffe, and that it did not as much come from its tactics, inferiority of the Allies, and employment of mobile warfare but from an army that was blitzed on Pervitin to turn it into a steamroller of a machine that could not be stopped, day or night.


2019 ◽  
Vol 19 (3) ◽  
pp. 189-196
Author(s):  
Jorge Flores-Aranda ◽  
Mathieu Goyette ◽  
Valérie Aubut ◽  
Maxime Blanchette ◽  
Frédérick Pronovost

Purpose The purpose of this paper is to document the experience of current and former methamphetamine users on their crystal meth use patterns and on their use of services related to their chemsex practice. Design/methodology/approach For qualitative component, two focus groups were formed with nine current users of methamphetamine and eight former users. Thematic analysis was performed to know their experiences. Findings All participants were already engaging in chemsex with various substances before they first started using methamphetamine. Methamphetamine use led some to slam (methamphetamine or mephedrone injection). Some participants report that their sexual experiences were intensified early in their chemsex practice. They reported feeling more confident with their partners, feeling like they are sexually attractive and overcoming their barriers to sexuality. The intensification of methamphetamine use and, in particular, injection change the positive perception of sexual life. Thus, for some participants, substance use takes more space and their sexual experiences become less satisfactory. Practical implications Participants report the services that address the phenomenon of chemsex are still scarce in Quebec province. In addition, the few services available aim to relearn a sober sexuality. However, the mourning of the positive aspects of chemsex on sexual experiences seems still very little discussed. Greater consideration of positive chemsex experiences is needed in services that address this issue. Originality/value This project documented the perception of pleasure related to sexual practices among regular methamphetamine users. Their perception of pleasure will help develop services adapted to their reality.


2016 ◽  
Vol 35 (11) ◽  
pp. 742-747 ◽  
Author(s):  
A. G. Franke ◽  
M. Soyka ◽  
S. Neumann

Zusammenfassung Gegenstand: Die illegale Droge „Crystal Meth“ (Methamphetamin) verbreitet sich in Deutschland und weltweit zunehmend. Während therapeutische Empfehlungen für Intoxikation und Missbrauch vorliegen, fehlen Handlungsempfehlungen der Behandlung der Abhängigkeit. Methode: Die selektive Übersicht basiert auf einer elektronischen Recherche in der Datenbank PubMed sowie überregionalen Bibliothekskatalogen zur Epidemiologie, Phänomenologie und Therapie der Methamphetaminabhängigkeit in Deutschland. Ergebnisse: Vereinzelt existieren erste klinische Empfehlungen der Behandlung von Methamphetaminabhängigkeit; spezialisierte Programme oder gar Leitlinien fehlen allerdings und werden derzeit erforscht. Schlussfolgerung und Klinische Relevanz: Die Methamphetaminabhängigkeit verbreitet sich und stellt Herausforderungen und Anpassungsleistungen an das deutsche Gesundheitssystem und angrenzende psychosoziale Hilfesysteme.


Sign in / Sign up

Export Citation Format

Share Document